Montelukast 5 Mg Chewable Tablets
Out of date information, search anotherPACKAGE LEAFLET: INFORMATION FOR THE USER [MONTELUKAST] 5 mg chewable tablets
Montelukast
For children from 6 to 14 years
Read all of this leaflet carefully before your child starts taking this medicine.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, please ask your doctor or pharmacist.
• This medicine has been prescribed for your child. Do not pass it on to others. It may harm them, even if their symptoms are the same as your child’s.
• If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
• 1. What [Montelukast] is and what it is used for
• 2. Before you take [Montelukast]
• 3. How to take [Montelukast]
• 4. Possible side effects
• 5. How to store [Montelukast]
• 6. Further information
1. WHAT [MONTELUKAST] IS AND WHAT IT IS USED FOR
[Montelukast] is a leukotriene receptor antagonist that blocks substances called leukotrienes. Leukotrienes cause narrowing and swelling of airways in your lungs. By blocking leukotrienes, [Montelukast] improves asthma symptoms and helps control asthma.
Your doctor has prescribed [Montelukast] to treat asthma, preventing your asthma symptoms during the day and night.
• [Montelukast] is used for the treatment of 6 to 14 year old patients who are not adequately controlled on their medication and need additional therapy.
• [Montelukast] may also be used as an alternative treatment to inhaled corticosteroids for 6 to 14 year old patients who have not recently taken oral corticosteroids for their asthma and have shown that they are unable to use inhaled corticosteroids.
• [Montelukast] also helps prevent the narrowing of airways triggered by exercise.
Your doctor will determine how [Montelukast] should be used depending on the symptoms and severity of your child's asthma.
What is asthma?
Astha is a long - term disease Asthma includes:
• Difficulty breathing because of narrowed airways.This narrowing of airways worsens and improves in response to various conditions.
• Sensitive airways that react to many things,such as cigarette smoke,pollen cold air, oor exercise.
• Swelling (inflammation)in the lining of the airways
• Symptoms of the asthma include: Coughing,wheezing and chest tightness.
2. BEFORE YOU TAKE [MONTELUKAST]
Tell your doctor about any medical problems or allergies you or your child has now or has had.
Do not take [Montelukast] if you or your child
• is allergic (hypersensitive) to Montelukast or any of the other ingredients of [Montelukast] (see 6. Further information).
Take special care with [Montelukast]
• If your or your child’s asthma or breathing gets worse, tell your doctor immediately.
• Oral [Montelukast] is not meant to treat acute asthma attacks. If an attack occurs, follow the instructions your doctor has given you for your child. Always have your inhaled rescue medicine for asthma attacks with you.
• It is important that you or your child take all asthma medications prescribed by your doctor. [Montelukast] should not be used instead of other asthma medications your doctor has prescribed for you or your child.
• Any patient on anti-asthma medicines should be aware that if you develop a combination of symptoms such as flu-like illness, pins and needles or numbness of arms or legs, worsening of pulmonary symptoms, and/or rash, you should consult your doctor.
• You or your child should not take aspirin or anti-inflammatory medicines (also known as nonsteroidal anti-inflammatory drugs or NSAIDs) if they make your asthma worse.
Use in children
For children 2 to 5 years old, [Montelukast] 4 mg chewable tablets are available.
For children 6 to 14 years old, [Montelukast] 5 mg chewable tablets are available.
[Montelukast] chewable tablets in children less than 2 years have not been established.
Taking other medicines
Some medicines may affect how [Montelukast] works, or [Montelukast] may affect how other medicines work.
Please tell your doctor or pharmacist if you or your child is taking or has recently taken other medicines, including those obtained without a prescription.
Tell your doctor if you or your child is taking the following medicines before starting [Montelukast]:
• phenobarbital (used for treatment of epilepsy)
• phenytoin (used for treatment of epilepsy)
• rifampicin (used to treat tuberculosis and some other infections)
Taking [Montelukast] with food and drink
[Montelukast] 5 mg chewable tablets should not be taken immediately with food; it should be taken at least 1 hour before or two hours after food.
Pregnancy and Breast-feeding
Use in pregnancy
Limited data concerning the exposed pregnancies do not suggest a causal relationship between montelukast and malformations (i.e. limb defects) that have been rarely reported in worldwide post marketing experience.
Women who are pregnant or intend to become pregnant should consult their doctor before taking [Montelukast]. Your doctor will assess whether you can take [Montelukast] during this time.
Use in breast-feeding
It is not known if [Montelukast] appears in breast milk. You should consult your doctor before taking [Montelukast] if you are breast-feeding or intend to breast-feed.
Driving and using machines
Montelukast is not expected to affect your ability to drive a car or operate machinery. However, individual responses to medication may vary. Certain side effects (such as dizziness and drowsiness) that have been reported very rarely with [Montelukast] may affect some patients’ ability to drive or operate machinery.
Important information about some of the ingredients of [Montelukast]
[Montelukast] chewable tablets contain aspartame.
Contains a source of phenylalanine. May be harmful for people with phenylketonuria. If you or your child has phenylketonuria you should take into account that each [Montelukast] 5 mg chewable tablet contains phenylalanine (equivalent to 0.168 mg phenylalanine per 5 mg chewable tablet).
3. HOW TO TAKE [MONTELUKAST]
• This medicine is to be given to a child under adult supervision.For children who have problems consuming a chewable tablet, an oral granule formulation is available.
• Your child should take only one tablet ofmontelukast] once a day as prescribed by your doctor.
• It should be taken even when your child has no symptoms or if he/she has an acute asthma attack.
• Always have your child take [Montelukast] as your doctor has told you. You should check with your doctor or pharmacist if you are not sure
For children 6 to 14 years of age:
One [Montelukast] 5 mg chewable tablet daily to be taken in the evening. [Montelukast] 5 mg chewable tablets should not be taken immediately with food; it should be taken at least 1 hour before or two hours after food.
If you or your child is taking [Montelukast], be sure that you or your child does not take any other products that contain the same active ingredient, montelukast.
If you or your child takes more [Montelukast] than you should
Contact your doctor immediately for advice.
There were no side effects reported in the majority of overdosage reports. The most frequently occurring symptoms reported with overdosage in adults and children included abdominal pain, sleepiness, thirst, headache, vomiting, and hyperactivity.
If you forget to take [Montelukast] or give [Montelukast] to your child
Try to give [Montelukast] as prescribed. However, if you or your child misses a dose, just resume the usual schedule of one tablet once daily.
Do not take a double dose to make up for a forgotten dose.
If you or your child stops taking [Montelukast]
[Montelukast] can treat you or your child’s asthma only if you or your child continues to take it. It is important to continue taking [Montelukast] for as long as your doctor prescribes. It will help control your or your child’s asthma. If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, [Montelukast] can cause side effects, although not everybody gets them.
In clinical studies with [Montelukast] 5 mg chewable tablets, the most commonly (in more than 1 in 100, or less than 1 in 10 treated patients) reported side effects thought to be related to [Montelukast] were:
• headache
Additionally, the following side effect was reported in clinical studies with [Montelukast] 10 mg film-coated tablets:
• abdominal pain
These were usually mild and occurred at a greater frequency in patients treated with [Montelukast] than placebo (a pill containing no medication).
Additionally, while the drug has been on the market, the following have been reported:
• increased bleeding tendency
• allergic reactions including rash, swelling of the face, lips, tongue, and/or throat which may cause difficulty in breathing or swallowing,
• behaviour and mood related changes[dream abnormalities,including
nightmares,hallucinations,irritability,feeling anxious,restlessness,agitation including aggressive behaviour, tremor, depression,trouble sleeping, suicidal thoughts and actions(in very rare cases)
• dizziness, drowsiness, pins and needles/numbness, seizure
• palpitations
• nosebleed
• diarrhoea, dry mouth, indigestion, nausea, vomiting
• hepatitis
• bruising, itching, hives, tender red lumps under the skin most commonly on your shins (erythema nodosum),
• joint or muscle pain, muscle cramps
• tiredness, feeling unwell, swelling, fever.
In asthmatic patients treated with Montelukast, very rare cases of a combination of symptoms such as flu-like illness, pins and needles or numbness of arms and legs, worsening of pulmonary symptoms and/or rash (Churg-Strauss syndrome) have been reported. You must tell your doctor right away if you or your child gets one or more of these symptoms.
Ask your doctor or pharmacist for more information about side effects. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
5. HOW TO STORE [MONTELUKAST]
• Keep out of the reach and sight of children.
• Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.
• Store in the original package in order to protect from light and moisture.
• Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION
What [Montelukast] contains
• The active substance is: montelukast
• [Montelukast] 5 mg chewable tablet contains montelukast sodium which corresponds to 5 mg of montelukast.
• The other ingredients are: Mannitol, microcrystalline cellulose, hyprolose (E 463), red iron oxide (E 172), croscarmellose sodium, cherry flavour (consisting of: maltodexrin, arabic gum, anisaldehyde, benzaldehyde, cinnamaldehyde, vanillin, heliotropin, ionons), aspartame (E951), and magnesium stearate.
What [Montelukast] looks like and contents of the pack
[Montelukast] 5 mg chewable tablets are pink, round, biconvex.
UK/H/2692/02/DC:
<In packs of: 7, 10, 14, 20, 28, 30, 50, 56, 84, 90, 98 and 100 tablets.>
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
Pharmathen S.A., 6 Dervenakion str., Pallini Attiki, 15351 Greece Tel: +30 210 6664300 Fax: +3- 210 6666749 E-mail: info@pharmathen.com
Manufacturer:
Pharmathen S.A., 6 Dervenakion str., Pallini Attiki, 15351 Greece Tel: +30 210 6664300 Fax: +3- 210 6666749 E-mail: info@pharmathen.com
This medicinal product is authorized in the Member States of the EEA under the following names:
UK/H/2692/01-02/DC: United Kingdom Czech Republic Germany
Estonia
Iceland
Lithuania
Poland
Slovak Republic
Alukast 5 mg chewable tablets Montecon 5 mg,
Montelukast Aurus 5 mg Kautabletten,
For children from 2 to 5 years Montelukast Portfarma 5mg Montelukast Portfarma 5mg Montelukast Portfarma 5mg Montelukast Quisisana Montecon 5 mg
This text was last revised in 06/2010